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Abstract
The ribonucleoprotein (RNP) complex is the essential transcription-replication machinery of the influenza virus. It is
composed of the trimeric polymerase (PA, PB1 and PB2), nucleoprotein (NP) and RNA. Elucidating the molecular
mechanisms of RNP assembly is central to our understanding of the control of viral transcription and replication and the
dependence of these processes on the host cell. In this report, we show, by RNP reconstitution assays and co-
immunoprecipitation, that the interaction between NP and polymerase is crucial for the function of the RNP. The functional
association of NP and polymerase involves the C-terminal ‘627’ domain of PB2 and it requires NP arginine-150 and either
lysine-627 or arginine-630 of PB2. Using surface plasmon resonance, we demonstrate that the interaction between NP and
PB2 takes place without the involvement of RNA. At 33, 37 and 41uC in mammalian cells, more positive charges at aa. 627
and 630 of PB2 lead to stronger NP-polymerase interaction, which directly correlates with the higher RNP activity. In
conclusion, our study provides new information on the NP-PB2 interaction and shows that the strength of NP-polymerase
interaction and the resulting RNP activity are promoted by the positive charges at aa. 627 and 630 of PB2.
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Introduction
Influenza is a contagious respiratory illness causing annual
epidemics and occasional pandemics. Influenza epidemics cause
between 250,000 and 500,000 deaths worldwide each year.
Pandemics can be highly lethal; for instance, the Hong Kong
Flu in 1968 killed approximately 1 million people worldwide [1].
The relatively mild and recently ended 2009 H1N1 pandemic
resulted in over 18,449 deaths [2]. The 1997 influenza A H5N1
outbreak resulted in 6 deaths among 18 cases, with a high
mortality rate of 33% [3]. Starting from 2003, the poultry-to-
human transmission of this virus has been reported in many
countries in Asia and Africa. There have been a total of 601
laboratory-confirmed human cases, of which 354 were fatal [4]. In
view of influenza virus having the ability to cause epidemics and
pandemics, a better understanding of how influenza virus
functions at the molecular level is essential.
Influenza A virus is a negative-sense RNA virus. Its genome
comprises eight segments of viral RNA (vRNA) encoding eleven or
twelve proteins, including surface glycoproteins haemagglutinin
(HA) and neuraminidase (NA), matrix protein M1, ion channel
M2, non-structural proteins NS1, NS2 and the newly identified
N40, nucleoprotein (NP), pro-apoptotic protein PB1-F2 and RNA-
dependent RNA polymerase proteins PA, PB1 and PB2 (reviewed
in ref. [5]). The ribonucleoprotein (RNP) complex is composed of
the trimeric polymerase, NP and vRNA. The RNP complex is the
essential element for transcription and replication of the viral
genome [6]. During transcription, the cap-binding domain of PB2
first binds the 59 7-methylguanosine cap of the host pre-mRNA
[7,8]. The endonuclease domain of PA then cleaves it 9–15
nucleotides downstream of the cap [9,10]. Then, PB1 uses this
short piece of capped RNA as primer for initializing the
transcription of mRNA [11,12]. The vRNA is replicated via a
complementary RNA (cRNA) intermediate in a primer-indepen-
dent process. The role of NP is to provide a structural framework
for vRNA and cRNA and it is also thought to be involved in
regulating viral transcription and replication and act as an
elongation factor (reviewed in ref. [13]).
RNPs are organized in a unique ‘7+1’ pattern in the virus [14]
and appear as supercoiled structures under electron microscopy
(EM) [15,16]. The structure of a recombinant mini-RNP that
contains a circular ring of nine NP molecules, a 248 nt-long RNA
and the trimeric polymerase, has been studied extensively by
single-particle imaging using EM. The first reconstruction reached
a resolution of 27 A ˚ at the NP ring and 36 A ˚ at the polymerase
[17]. The resolution of the polymerase was soon improved to
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proposed [18]. Using cryo-EM, the resolutions at the NP ring and
the polymerase were further raised to 12 and 18 A ˚ respectively,
which allowed the fitting of the recently determined crystal
structures of NP and the partial PA-PB1 complex into the three-
dimensional (3D) reconstruction [19]. The structure also suggested
specific interactions of the PB1 and PB2 polymerase subunits with
two molecules of NP adjacent to the polymerase. A number of
advancements have been made in the x-ray and NMR structure
determination of the different components of RNP since 2006.
The atomic structures resolved now cover more than half of the
sequence of the trimeric polymerase (reviewed in ref. [20]). In
particular, we and others have determined the full protein
structure of NP [21,22]. NP was crystallized as a trimer and is
organized into a head domain, a body domain and a tail loop. The
structure of the PB2 ‘627’ domain, which contains the host-
determining residue K/E627, has also been resolved [23,24].
The phenotypic differences between human and avian influenza
viruses have been extensively studied throughout the decades.
Human influenza viruses replicate more efficiently in mammalian
cells than avian cells, and the same is true for avian viruses in avian
cells compared to mammalian cells [25]. This host range
restriction is conferred in part by PB2 [26–28], in which seventeen
host-determining residues have been identified [29]. The best
characterized residue, at position 627, is predominantly a lysine in
human influenza viruses and a glutamate in avian influenza
viruses. Avian polymerase with E627 was shown to be selectively
restricted in human cells [30,31]. Avian viruses with an E627K
mutation have shown improved growth in human cells and
enhanced virulence in mice. PB2 with K627 was also shown to
replicate more efficiently at 33uC (i.e. upper respiratory tract in
human) than PB2 with E627 [32–34].
Before the EM 3D reconstruction of the RNP suggesting specific
polymerase-NP interaction, there was already biochemical evi-
dence for such interaction. NP was found to interact with PB1 and
PB2 but not PA, in both a recombinant system and in virus-
infected cells [35,36]. Three regions of NP (aa. 1–161, 255–340
and 340–465) were found to interact independently with PB2,
while the C-terminus of NP (aa. 465–498) was found to inhibit NP-
PB2 binding [35]. Later, two PB2 fragments (N-terminal aa. 1–
269 and C-terminal aa. 580–683) were also identified as being
responsible for NP-binding [37]. There are, however, considerable
overlaps of the NP- and PB1- binding sites on PB2. Two recent
functional studies have suggested that the E627K mutation can
strengthen the NP-polymerase interaction in avian influenza virus
RNPs in human cells [38,39]. In the present report, we identify
residues in NP and PB2 that mediate NP-polymerase interaction
and show how the strength of the interaction is related to the RNP
activity.
Results
A single point mutation R150A in NP abolishes RNP
activity in an H5 polymerase background, but not an H1
background
The resolution of the NP crystal structure [21,22] has enabled
the dissection of its functional domains. We have previously
identified, by surface plasmon resonance (SPR), three regions in
NP (G1 [R74, R75, R174, R175, R221], G2 [R150, R152, R156,
R162] and a flexible basic loop [aa. 74–88]) which are involved in
RNA binding [21]. During the investigation, we have identified an
NP mutant (NP-R150A) which had normal RNA binding affinity
(Fig. 1A) and NP-NP interaction (Fig. 1B), but displayed different
RNP activities when analysed with polymerases from different
influenza virus subtypes.
The R150A H5 NP mutant plasmid was co-transfected with
plasmids expressing polymerase proteins [either from A/Hon-
gKong/156/97(H5N1) or A/WSN/33(H1N1)] and a reporter
plasmid expressing NA vRNA into 293T cells. The amounts of NP
plasmids were adjusted to give similar protein expression levels. A
plasmid expressing wild-type H5 NP was used as the positive
control, while an empty plasmid was the negative control. At 48 h
post-transfection, total RNA was extracted, and the vRNA, cRNA
and mRNA levels of the reporter gene were quantified by a primer
extension assay, followed by polyacrylamide gel electrophoresis
and autoradiography (Fig. 1C and 1D). The various RNA levels
were normalized to the internal 5 S rRNA control and compared
with those of the wild-type NP.
In an H5 polymerase background, the R150A mutation in NP
has led to a total loss in its RNP activity (Fig. 1C). In an H1
polymerase background, the R150A mutation could however
retain about half of its activity compared to wild-type (Fig. 1D).
This suggests that the defective phenotype of the NP R150A
mutation is strain-specific.
NP R150A associates with the polymerase complex and
forms an active RNP in the presence of WSN(H1) PB2, but
not H5 PB2
Next, we investigated why the defective NP R150A phenotype
was strain-specific. We swapped the polymerase subunits between
H5 and WSN(H1) and performed RNP reconstitution assays with
either wild-type NP or the R150A mutant (Fig. 2A). All
combinations of polymerases with wild-type NP gave detectable
RNP activity, although some were less active than others (Fig. 2A,
odd numbered lanes). The variation of RNP activities may be due
to differences in the compatibility of the polymerase subunits from
H1 and H5 subtypes. On the other hand, in the presence of NP
R150A, active RNP activity was obtained when PB2 was from
WSN(H1) (lanes 2, 8, 10) but not from the H5 subtype (lanes 4, 6,
12). PB2 is therefore the determining factor responsible for the
differential phenotypes of the NP R150A mutant in WSN(H1) and
H5 polymerase backgrounds.
Why does the NP R150A form an active RNP with WSN(H1)
PB2 but not H5 PB2? We hypothesized that this may be related to
the interaction between NP and the polymerase complex. To test
this, NP wild-type or the NP R150A mutant were co-expressed
with the NA vRNA, H5 PB1, WSN(H1) or H5 PB2 and myc-
tagged H5 PA in 293T cells. Co-immunoprecipitation was
performed at 48 h post-transfection with anti-myc antibody,
followed by detection of NP and the myc-tagged PA by western
blotting (Fig. 2B). Wild-type NP was co-immunoprecipitated in the
presence of myc-tagged polymerase complex containing either H5
or WSN(H1) PB2. However, mutation of NP R150A significantly
reduced its interaction with the polymerase complex containing
H5 PB2, but not WSN(H1) PB2. Similar results were obtained in
the absence of NA vRNA (Fig. S1).
Replacing the C-terminus of H5 PB2 with that of WSN(H1)
PB2 restores the RNP activity and NP-polymerase
interaction of the NP R150A mutant
Alignment of the WSN(H1) and H5 PB2 amino acid sequences
revealed an identity of 94% (results not shown). We set out to
investigate which region in the WSN(H1) PB2 was responsible for
the interaction with NP by creating a series of chimeric WSN(H1)
and H5 PB2 proteins (Fig. 3A). A luciferase reporter assay [40] was
used to measure the overall RNP activity. A plasmid encoding a
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either wild-type or R150A NP, PA, PB1 and the various PB2
constructs. A plasmid encoding green fluorescent protein (GFP)
was also co-transfected as a control. The RNP activity was
reported as the ratio of luciferase activity to GFP level.
Transfection of all six chimeric PB2 mutants with wild-type NP
resulted in detectable RNP activity, indicating that they were
functional (Fig. 3B). As observed before, RNP with wild-type H5
PB2 and NP R150A mutation did not give significant activity
(Fig. 3C, H5-PB2). Replacing the N-terminal region of H5 PB2
with aa. 1–279 of WSN(H1) PB2 did not increase the RNP activity
(Fig. 3C, H1[1–279]H5[280–759]-PB2). This indicates that the N-
terminus of WSN(H1) PB2 could not rescue the defective
phenotype of the NP R150A. On the other hand, replacing aa.
551–759 of H5 PB2 by the corresponding C-terminal region of
WSN(H1) PB2 rendered the RNP active (Fig. 3C, H5[1–
550]H1[551–759]-PB2).
Co-immunoprecipitation of wild-type or R150A NP with the
H5[1–550]H1[551–759]-PB2 chimeric protein was then per-
formed. It was found that H5[1–550]H1[551–759]-PB2 could
restore the NP-polymerase interaction with the NP R150A mutant
(Fig. 3D). Taken together, these experiments showed that the C-
terminus of WSN(H1) PB2 can overcome the inhibitory effect of
NP R150A mutation in the background of an H5 polymerase.
Residues 627 and 630 in PB2 are crucial for the
NP-polymerase interaction in mammalian cells
Sequence alignment of the C-terminus of PB2 of the two strains
was performed to identify the particular residues in the C-terminus
of PB2 (aa. 551–759) which caused the differential phenotypes in
the presence of the NP R150A mutant. 13 polymorphic amino
acid residues were found between the two strains (Fig. 4A). We
constructed nine single-point and two double-point H5 PB2
mutants with polymorphic amino acid residues from WSN(H1)
PB2. The expression levels of these PB2 mutants were normalized
and the RNP activities of the mutants were measured using a
luciferase reporter assay with wild-type NP (Fig. 4B, bars 1–12) or
NP R150A (Fig. 4C, bars 1–12).
All eleven H5 PB2 mutants could form active RNPs with wild-
type NP (Fig. 4B, bars 1–12). However, only one double-point
mutant ([E627K,R630G]-H5-PB2) could recover the RNP activity
in the presence of the NP R150A mutant (Fig. 4C,
[E627K,R630G]-H5-PB2). To test whether K627 or G630 of
WSN(H1) PB2 was the key residue, we constructed two additional
point mutants (E627K-H5-PB2 and R630G-H5-PB2). It was
found that the E627K mutation in H5 PB2 gave normal RNP
activity with wild-type NP and could compensate for the NP
R150A mutation (Fig. 4B and 4C, bar 14). A co-immunoprecip-
itation experiment also demonstrated that the E627K-H5-PB2
restored the NP-polymerase interaction of NP R150A mutant
(Fig. 4D, lanes 5–8).
Surprisingly, the other mutant R630G-H5-PB2, which contains
E627, could not produce significantly active RNP even with wild-
type NP (Fig. 4B, bar 15), although the mutant was expressed to
similar level as the wild-type PB2 in 293T cells (data not shown).
We also changed K627 to E in WSN(H1) PB2, which has already
got G630 (K627E-H1-PB2). RNP activity with wild-type NP was
found to be greatly reduced (Fig. 4B, bar 16). Co-immunoprecip-
itation experiments also showed that both mutants (R630G-H5-
PB2 and K627E-H1-PB2) lost nearly all NP-polymerase interac-
tion with wild-type NP (Fig. 4D, lanes 9–16).
From the above observations (summarized in Table 1), we can
make the following conclusion. Residues at positions 627 and 630,
but not the origin of PB2, determine the NP-polymerase affinity
and RNP activity (rows 1–8). With the WSN(H1) PB2 genotype
(K627 and G630), both wild-type NP and R150A NP could form a
functional RNP with similar polymerase activity (rows 1–4). With
the H5 PB2 genotype (E627 and R630), only the wild-type NP but
not the R150A NP could form a functional RNP (rows 9–10). This
showed that a positively charged residue, either at position 627 or
630, is required to form a functional RNP. Without a positively
charged amino acid residue at either of these positions, PB2 is
inactive in producing functional RNP and NP-polymerase
interactions (rows 5–8). In addition, it is crucial to have an
arginine residue at position 150 in NP if there is a positively
charged residue at position 630, but not at position 627 of PB2
(rows 1–2, 9–10). This suggests that polymerase with K627-
containing PB2 does not require R150 in NP for the interaction
with NP.
To find the interaction of polymerase with NP and the RNP
activities at different temperatures, co-immunoprecipitation of NP
and luciferase assays on PB2 with E627/R630 (wild-type H5),
E627/G630, K627/R630, K627/G630 were performed at 33, 37
and 41uC in mammalian cells (Fig. 5). Similar levels of the
different PB2 variants were co-immunoprecipitated by myc-tagged
PA at all tested temperatures (Fig. 5A). In the absence of positive
charges at positions 627 and 630, the affinity to NP and the RNP
activity were found to be low at all tested temperatures (Fig. 5A,
lane 7; Fig. 5B, R630G-H5). On the other hand, polymerase
carrying wild-type H5 PB2, which has E627 and R630, showed
low affinity to NP and low RNP activity at 33uC, but increased
significantly at 37 and 41uC (Fig. 5A, lane 1; Fig. 5B, WT-H5).
Both the wild-type H5 PB2 and [E627K,R630G]-H5 PB2 carry
one positive charge at the concerned region, the former with R630
while the latter with K627. K627 led to more efficient interaction
with NP and higher RNP activity than R630 (Fig. 5A, lanes 1 and
3; Fig. 5B, WT-H5 and [E627K,R630G]-H5). Compared to the
polymerase carrying wild-type H5 PB2, more positive charges at
aa. 627 and 630 gave a higher affinity with NP and a higher RNP
activity at all tested temperatures (Fig. 5A, lanes 1 and 5; Fig. 5B,
WT-H5 and E627K-H5).
The ‘627-domain’ of PB2 directly interacts with NP,
without the involvement of RNA
After the identification of the crucial residues in PB2 (K627 and
R630) and NP (R150) required for NP-polymerase interaction, we
then investigated how NP and PB2 interact. The NP-PB2
interaction could be either direct or indirect, or even involving
RNA, as both NP and PB2 have been shown to possess RNA
binding activities [21,24]. To understand the mode of interaction,
Figure 1. The R150A NP mutant shows different activities in H5 and WSN(H1) polymerase backgrounds. (A) SPR of different
concentrations of NP R150A mutant against immobilized RNA. (B) Co-immunoprecipitation of flag-tagged NP mutants with their myc-tagged
counterparts. ‘+’ refers to the presence of the anti-myc antibodies while ‘2’ indicates their absence. (C) The wild-type and R150A mutant NP were
subjected to RNP reconstitution assay in an H5 background and viral RNA (NA) levels were quantified by primer extension. A representative result of
three independent experiments is shown. RNA levels of the NP R150A mutant were compared to those of wild-type NP, which was set to 100%. 5S
rRNA was used to normalize the m-, c- and v-RNA levels. The quantitation represents the mean percentage 6 standard deviations from three
experiments. (D) RNP reconstitution assay of wild-type and R150A mutant NP in an WSN(H1) background (*, P,0.05; **, P,0.005).
doi:10.1371/journal.pone.0036415.g001
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3000. We expressed NP and the PB2 ‘627-domain’ (aa. 538–693)
in E. coli and purified the protein to high homogeneity using
established protocols [21,23]. The purified PB2 ‘627-domain’ was
covalently immobilized on an NHS-column. The column was then
incubated with purified NP. After extensive washing, the bound
protein, if any, was eluted with a high salt buffer. It was found that
the PB2 ‘627-domain’ interacts with NP (Fig. 6A). An empty
column was also incubated with purified NP as a negative control,
with no NP being eluted (data not shown).
Figure 2. The R150A NP mutant forms a functional association with polymerases containing WSN(H1) PB2. (A) RNP reconstitution assay
with gene-swapped polymerases and wild-type or R150A mutant NP. RNA levels were compared to those with wild-type NP in H5 polymerase
background, which was set to 100% (Lane 3). A representative result of three independent experiments is shown. P-values are calculated versus wild-
type NP for each set of polymerase combination (*, P,0.05; **, P,0.005). (B) Co-immunoprecipitation of wild-type and R150A mutant NP with Myc-
tagged polymerase carrying either H5 or WSN(H1) PB2.
doi:10.1371/journal.pone.0036415.g002
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chip by amine coupling. Purified NP was allowed to pass through
the chip in a concentration series (Fig. 6B). The kinetic parameters
were measured, the binding curves were fitted and the affinity of
the interaction was calculated. The best-fitted model is the ‘1:1
Langmuir model’’, which is consistent with the phenomenon that
one RNP contains one copy of PB2. Wild-type NP bound wild-
type H5 PB2 ‘627-domain’ through direct protein-protein
interaction, with an affinity of 252 nM (Table 2). To determine
if RNA played a role in the interaction, a 24-nt 29-O-methylated
Figure 3. Polymerase activity assay and co-immunoprecipitation of domain-swapped PB2 mutants. (A) Construct design of domain-
swapped PB2 mutants. (B and C) RNP reconstitution assay of domain-swapped PB2 with (B) wild-type and (C) R150A mutant NP. A plasmid encoding
GFP was co-transfected for data normalization purposes. The RNP activity was reported as the ratio of luciferase activity to the GFP level. The RNP
activities of the domain-swapped PB2 proteins were compared to that of WSN(H1)-PB2. The bar chart represents the mean ratio 6 standard
deviations from three independent experiments (*, P,0.05). (D) Co-immunoprecipitation of wild-type and R150A mutant NP with Myc-tagged
polymerase carrying either H5 or H5[1–550]H1[551–759] PB2.
doi:10.1371/journal.pone.0036415.g003
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different molar ratios. The NP/RNA mixture was allowed to pass
through the chip and it was found that the NP-PB2 ‘627-domain’
interaction decreased with increasing amount of RNA (Fig. 6C).
Thus, the presence of RNA caused an inhibitory effect suggesting
that RNA is not involved in the interaction.
To test if the crucial residues (PB2 K627, R630 and NP R150) for
NP-polymerase binding and RNP activities are related to this direct
NP-PB2 ‘627-domain’ interaction, we cloned the [E627K,R630G]
and R630G mutations separately into H5 PB2 ‘627-domain’ for
bacterial protein expression and purification. The [E627K,R630G]
mutant mimics the genotype of WSN(H1) PB2. The binding
affinities of these H5 PB2 ‘627-domain’ mutants with NP were
analyzed (Table 2). It was found that the NP R150A variant bound
12.9 fold weaker than wild-type NP to the wild-type H5 PB2 ‘627-
domain’ (Fig. 6D, Table 2). This correlates with the defective
phenotype of NP R150A mutant with H5 PB2 (Fig. 2A and 2B).
When the H5 PB2 ‘627-domain’ [E627K,R630G] variant was
immobilized on the sensor chip, both wild-type and mutant R150A
NP showed high binding affinities (Fig. 6E, Table 2). This again
correlates with the RNP activity and NP-polymerase interaction of
NP R150A mutant with [E627K,R630G]-H5-PB2 (Fig. 4C and
4D). On the other hand, neither wild-type nor the R150A NP
mutant interacted with immobilized H5 PB2 R630G (Fig. 6F). This
also agrees with the lack of RNP activity and NP-polymerase
interaction of R630G-H5-PB2 (Fig. 4B, 4C and 4D). Therefore, we
conclude that the direct protein-protein interaction of NP and PB2
‘627-domain’ plays a crucial role in the NP-polymerase interaction
as well as the activity of the RNP complex.
Discussion
In this report, the amino acid residues K627 and R630 in the
’627-domain’ of PB2 were found to be important for mediating the
interaction between NP and polymerase. In addition, a region of
NP involving the conserved amino acid residue 150 was also found
to be important in mediating such interaction. These results
facilitate our understanding of the molecular mechanisms of RNP
assembly of influenza A viruses.
Using H5 and WSN strains as models, our data indicate that
either K627 or R630 in PB2 can mediate a functional NP-
polymerase interaction. Results from virus replication assays also
support this conclusion. Avian influenza virus isolates HK156 and
MZ237, which contain E627 and R630, were shown to form
plaques and possess transcription-replication activities at 37uCi n
293T cells [38]. A reassortant WSN virus containing polymerase
and NP genes from the avian isolate MZ reached similar viral
titers as a reassortant WSN virus with polymerase and NP genes
from the human isolate P908 at 48 hpi on MDCK cells, although
it exhibited slower growth during the first 30 hpi [39]. These
studies showed that viruses containing R630, but not K627, in
PB2 could replicate efficiently in mammalian cells. The WSN virus
with PB2 containing K627 and G630, was also found to produce
high virus titer at 37uC in MDCK cells. This virus also had high
polymerase activity in 293T and Cos7 cells [30]. However, when
both K627 and R630 were absent, the virus could hardly replicate
in mammalian cells. The WSN virus with PB2 K627E mutation
and G630 gave low polymerase activity and formed very few
plaques in MDCK cells [30]. Interestingly, when PB2 with E627
and G630 was co-expressed with NP, an interaction was observed
[30]. However, it was shown previously that the N-terminal 1–269
amino acids of PB2 can also interact with NP [37] and we
speculate that the observed interaction could have been mediated
primarily by the N-terminal region of PB2. When the whole RNP
complex is expressed, the interaction between the polymerase
carrying PB2 K627E mutation and NP in mammalian cells is
weak, as observed by us (Fig. 4B) and other [30].
The PB2 ‘627-domain’ construct used in the SPR experiment
lacks the N-terminal region of PB2, which was shown to bind NP
[37]. Yet the PB2 ‘627-domain’ is independently folded and
residue 627 at the domain was shown to affect the NP-polymerase
interaction [38]. According to the atomic structure of the PB2
‘627-domain’ [23,24], aa. 627 and 630 are on a flexible loop, and
the conformation is likely to change upon interaction with NP.
How exactly these residues contribute to the interaction would
need the elucidation of the structure of the PB2-NP complex.
Concerning the involvement of RNA, we showed by SPR
experiments that RNA in fact inhibits the NP-PB2 ‘627-domain’
interaction, suggesting that RNA is not involved in the interaction
between PB2 and NP in RNP.
There are more than 10,000 PB2 sequences from various
influenza strains in the NCBI database. Avian viruses and the
2009 H1N1 pandemic strain have the combination of E627 and
R630 (61.0% of all PB2 sequences). Human viruses typically have
the combination of K627 and R630 (38.2% of all PB2 sequences),
with the exception of the 2009 H1N1 pandemic. It is noted that
the combination of K627 and G630 is confined to the WSN strain.
Avian influenza viruses carrying PB2 E627 do not replicate
efficiently at 33uC in mammalian cells [32–34]. We have found
that polymerase from human H5N1 isolate with PB2 E627 has
lower RNP activity at 33uC than those with PB2 mutated to K627
(Fig. 5). With PB2 E627K mutation, the avian viruses have
improved growth in mammalian cells and enhanced virulence in
mice and possibly humans [32–34]. The phenotypic differences of
K/E627 are likely brought by either an inhibitory co-factor on
E627 or an adaptive co-factor on K627 in human cells [30,31].
We observe at all tested temperatures that stronger the
interaction between NP and polymerase, better their RNP
activities (Fig. 5). At temperatures in both the mammalian
respiratory tract (33uC) and the avian intestinal tract (41uC),
polymerase with more positive charges at PB2 aa. 627 and 630
interacts better with NP and confers higher RNP activity (Fig. 5).
This coincides with the previous findings that (1) more NP was co-
purified by strep-PB2 tagged human-like polymerase than avian-
like polymerase [39]; and (2) E627K mutation in an avian PB2
strengthened the NP-polymerase interaction in human cells [38].
To conclude, this work contributes to our understanding of how
NP interacts with PB2 and polymerase in influenza virus RNP. A
region of NP involving amino acid residue 150 was found to
interact with K627 or R630 of PB2. The direct correlation of the
strength of NP-polymerase interaction and the RNP activity at
different physiological temperatures was established. These
provide new information of the requirements of the replication
machinery of the influenza viruses.
Figure 4. K627 and R630 are crucial for the RNP activity and NP-PB2 interaction. (A) Sequence alignment of H5 and WSN(H1) PB2
C-terminal region (aa. 551–759). The arrows denote the differences. (B and C) RNP reconstitution assay of PB2 point mutants with (B) wild-type or (C)
R150A mutant NP. The mean RNP activities from three independent experiments of the PB2 mutants were compared to those of wild-type H5-PB2 (*,
P,0.05). (D) Co-immunoprecipitation of wild-type and R150A mutant NP with Myc-tagged polymerase variants in 293T cells at 37uC.
doi:10.1371/journal.pone.0036415.g004
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Biological Materials
The 293T cell line (ATCC, Manassas, VA, USA) was cultivated
in minimal essential medium (MEM) (Invitrogen, Carlsbad, CA,
USA) with 10% fetal calf serum (Invitrogen). Anti-NP and anti-
PB2 sera were prepared by immunizing rabbits with purified NP
and the N-terminus of PB2. Anti-myc antibody (Cell Signaling,
Danvers, MA, USA), anti-beta-actin antibody (GenScript, Piscat-
away, NJ, USA) were purchased commercially. Plasmids pcDNA-
PB1, pcDNA-PB2, pcDNA-PA, pcDNA-NP and pPOLI-NA-RT
have been described previously [41,42]. pEGFP and pPolI-Luc-
RT are gifts from L.L.M. Poon and have been described [40]. NP
and PB2 mutants were cloned into pcDNA3 (Invitrogen) for the
expression of untagged NP and PB2 variants in 293T cells. H5 PA
was cloned into pcDNA3.1/myc-His (Invitrogen) for the expres-
sion of myc-tagged PA in 293T cells.
RNA analysis by primer-extension assay
Human kidney 293T cells were used to reconstitute RNP
complexes. 1 mg of each of the pcDNA-PB1, pcDNA-PB2,
pcDNA-PA, pcDNA-NP, and pPOLI-NA-RT plasmids were
diluted to a total volume of 250 ml in OptiMEM (Invitrogen)
and subsequently added to a mix of 7.5 ml of Lipofectamine 2000
(Invitrogen) in 250 ml OptiMEM. The transfection mixture was
incubated for 30 minutes before adding to 1.5 ml (about 10
6 cells)
293T cells in suspension in minimal essential medium (MEM)
containing 10% fetal calf serum in 35-mm dishes. Cells were
incubated at 37uC, harvested 48 hours post-transfection, and total
RNA was extracted by TRIzol reagent (Invitrogen).
Primer extension assays were performed as described previously
[42,43]. Briefly, an excess of DNA primer (about 10
5 cpm),
labeled at its 59 end with
32P, was mixed with 5 mg of total RNA in
5 ml of water, and denatured at 95uC for 3 minutes. The mixture
was cooled on ice and subsequently incubated at 45uC for 1 hour
with the addition of 50 U SuperScript II RNase H
2 reverse
transcriptase (Invitrogen) in First Strand Buffer (Invitrogen). Two
NA gene-specific primers and one 5 S ribosomal RNA primer
(used as an internal control) were used in the same reverse
transcription reaction: 59-GGACTAGTGGGAGCATCAT-39 (to
detect vRNA), 59-TCCAGTATGGTTTTGATTTCCG-39 (to
detect mRNA and cRNA) and 59-TCCCAGGCGGTCTCC-
CATCC-39 (to detect 5 S rRNA). Reactions were stopped by the
addition of 8 ml 90% formamide and heating at 95uC for
3 minutes. Transcription products were analyzed on 6% poly-
acrylamide gels containing 7 M urea in TBE buffer and detected
by autoradiography. Phosphorimage analysis by ImageQuant TL
(GE Healthcare, Waukesha, WI, USA) was used for quantification.
An unpaired Student’s t-test was used for analysis of significance.
Polymerase activity analysis by luciferase assay
0.125 mg of each of the pcDNA-PB1, pcDNA-PB2, pcDNA-PA,
pcDNA-NP, and pPOLI-Luc-RT plasmids and 0.0625 mgo f
pEGFP plasmid were diluted to a total volume of 12.5 mli n
OptiMEM (Invitrogen) and subsequently added to a mix of 1.05 ml
of Lipofectamine 2000 (Invitrogen) in 12.5 ml OptiMEM. The
transfection mixture was incubated for 30 minutes in the 96-well
plate before 75 ml (about 10
5 cells) 293T cells in minimal essential
medium (MEM) containing 10%fetal calf serum was added intothe
well. GFP fluorescent signal was first measured 48 h post-
transfection by Victor 2 Multilabel plate reader (Perkin Elmer,
Waltham, MA, USA). Afterwards, cells were lysed by Steady-Glo
assay reagent (Promega, Madison, WI, USA) for 5 minutes, and the
luminescence signal was measured. The polymerase activity was
reported as the ratio of GFP signal to luminescence signal. An
unpaired Student’s t-test was used for analysis of significance.
Co-immunoprecipitation of NP-polymerase and NP-NP
1 ug each of Myc-tagged PA, untagged PB1, PB2 and NP and
pPol-NA-RT plasmids were transfected into 10
6 human kidney
293T cells in suspension. Co-immunoprecipitation was performed
48-hours post-transfection. Cells were resuspended in 50 mM
Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100 (co-IP buffer) and lysed by sonication. The lysate was
centrifuged at 16000 g for 10 minutes at 4uC. The supernatant
was incubated at 4uC overnight with or without anti-myc
antibody. The mixture was then incubated with protein-A beads
for 1.5 hours at 4uC with shaking. The beads were centrifuged and
washed with co-IP buffer four times before being boiled in SDS-
loading dye and analyzed by western blotting. Experiment to study
NP homo-oligomerization was performed as described [44]. 1 ug
each of untagged and myc-tagged NP plasmids were transfected
Table 1. Summary of the key findings.
PB2 NP Phenotype







1 [E627K, R630G] -H5 PB2 K G WT R Active Yes Yes
2 R150A A Active Yes Yes
3 WT-H1 PB2 K G WT R Active Yes n/a
4 R150A A Active Yes n/a
5 R630G-H5 PB2 E G WT R Inactive No No
6 R150A A Inactive No No
7 K627E-H1 PB2 E G WT R Inactive Very weak n/a
8 R150A A Inactive No n/a
9 WT-H5 PB2 E R WT R Active Yes Yes
10 R150A A Inactive Very weak Largely weakened
Note:
‘n/a’ refers to not available.
doi:10.1371/journal.pone.0036415.t001
NP-Polymerase Interaction and Activity
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36415into the 293T cells. 150 U RNaseA (Sigma) was added to the
supernatant after centrifugation.
Expression and purification of NP
Maltose binding protein (MBP)-tagged NP was expressed in
Escherichia coli BL21(DE3)pLysS. The cells were lysed by
sonication, and the lysate was passed through an amylose column
(New England Biolabs, Ipswich, MA, USA). Bound protein was
eluted with a 0–20 mM maltose gradient in 20 mM sodium
phosphate (pH 6.5) and 150 mM NaCl. The eluate was incubated
with thrombin (100 U) (Sigma) and RNase A (100 U) (Sigma) at
4uC overnight to remove MBP from NP and then passed through
a heparin HP column (GE Healthcare). NP was eluted with a 0–
1.5 M NaCl gradient in the same buffer. Gel filtration was
performed with Superdex 200 (GE Healthcare). RNase A was
removed after passing through heparin HP column and gel
filtration. NP R150A mutant was generated by site-directed
mutagenesis of the wild-type pRSETMBP-NP plasmid [21]
following a standard protocol, and was purified as described for
the wild-type protein.
Figure 5. Temperature-dependent NP-PB2 interaction and polymerase activity. (A) Co-immunoprecipitation of wild-type NP by Myc-
tagged polymerase carrying different PB2 at 33uC, 37uC and 41uC. (B) RNP reconstitution assay of PB2 point mutants at 33uC, 37uC and 41uC.
doi:10.1371/journal.pone.0036415.g005
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36415Figure 6. Biophysical characterization of the NP-PB2 ‘627-domain’ interactions. (A) Pull down assay to analyze NP-PB2 interaction. Purified
PB2 ‘627-domain’ was covalently immobilized onto an NHS column. Purified NP was then applied and eluted after extensive washing. (B) SPR analysis
of NP-PB2 interaction. Wild-type PB2 ’627-domain’ was immobilized on a CM5 chip. NP in increased concentration was applied to the chip surface.
The response differences of experimental and control flow cells are reported (individual diamonds). Solid lines are the fitted curves. (C) Wild-typeN P
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The method has been described previously [23]. Briefly, His-
tagged PB2 ‘627-domain’ was expressed in Escherichia coli
BL21(DE3). The cells were lysed by sonication in lysis buffer
(30 mM Tris-HCl, 200 mM NaCl, pH 7.0). The lysate was then
passed through a His column (GE Healthcare). Bound protein was
washed with lysis buffer, followed by sequential washes with 1 M
NaCl, 50 mM imidazole and 75 mM imidazole in lysis buffer to
reduce non-specific binding. His-tagged PB2 ‘627-domain’ was
eluted with 500 mM imidazole in lysis buffer. Gel filtration was
then performed with Superdex 75 (GE Healthcare) in lysis buffer
or in phosphate buffered saline (PBS).
In vitro pull down assay
Purified wild-type PB2 ‘627-domain’ was covalently immobilized
on an NHS column, according to the manufacturer’s instructions
(GE Healthcare). Wild-type NP in PBS was then applied to the
column and incubated for 1 h at room temperature. The column
was washed with at least 20 column volumes of PBS. Bound protein
was eluted with 1.5 M NaCl in PBS and analyzed by SDS-PAGE.
SPR analysis of NP-PB2 ‘627-domain’ and NP-RNA
interaction
Purified wild-type, [E627K,R630G] and R630G H5 PB2 ‘627-
domain’ variants were individually immobilized on a CM5 sensor
chip (GE Healthcare) using an amine coupling kit until the surface
density reached 700–800 response units (RU). A blank flow cell
was used as a control. Wild-type and R150A NP variant in a series
of concentrations were allowed to flow through the flow cells. A 29-
O-methylated RNA oligonucleotide with the sequence 59 UUU
GUU ACA CAC ACA CAC GCU GUG 39 was mixed with the
protein variants in some experiments to assess the effect of RNA
on the NP-PB2 ‘627-domain’ interaction. SPR measurements
were carried out with BIAcore 3000 at 25uC. The response in the
control flow cell was subtracted from that of the experimental flow
cells and the data were analyzed with BIAevaluation v. 4.1 using
the model of ‘1:1 Langmuir binding’, for the calculations of
association constant, dissociation constant and the affinity of the
interaction. No mass transfer effect was observed. For NP-RNA
interaction study, biotinylated 29-O-methylated RNA oligonucle-
otide with the above sequence was immobilized on an SA sensor
chip (GE Healthcare) until the surface density reached 30–35 RU.
NP variants in different concentrations were allowed to pass
through the chip surface.
Supporting Information
Figure S1 Co-immunoprecipitation of wild-type and
R150A mutant NP with Myc-tagged polymerase carrying
either H5 or WSN(H1) PB2, in the absence of vRNA.
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